mlsanityData to 7 Oct 2026

MAC-AMP: A Closed-Loop Multi-Agent Collaboration System for Multi-Objective Antimicrobial Peptide Design

arXiv 2602.14926 ↗First posted 16 Feb 2026cs.AIcited by 0

On the map: LLM agents and tool use → Medical and scientific domain agents

Abstract (arXiv)

To address the global health threat of antimicrobial resistance, antimicrobial peptides (AMP) are being explored for their potent and promising ability to fight resistant pathogens. While artificial intelligence (AI) is being employed to advance AMP discovery and design, most AMP design models struggle to balance key goals like activity, toxicity, and novelty, using rigid or unclear scoring methods that make results hard to interpret and optimize. As the capabilities of Large Language Models (LLM) advance and evolve swiftly, we turn to AI multi-agent collaboration based on such models (multi-agent LLMs), which show rapidly rising potential in complex scientific design scenarios. Based on this, we introduce MAC-AMP, a closed-loop multi-agent collaboration (MAC) system for multi-objective AMP design. The system implements a fully autonomous simulated peer review-adaptive reinforcement learning framework that requires only a task description and example dataset to design novel AMPs. The novelty of our work lies in introducing a closed-loop multi-agent system for AMP design, with cross-domain transferability, that supports multi-objective optimization while remaining explainable rather than a 'black box'. Experiments show that MAC-AMP outperforms other AMP generative models by effectively optimizing AMP generation for multiple key molecular properties, demonstrating exceptional results in antibacterial activity, AMP likeliness, toxicity compliance, and structural reliability.

Key facts. No citing papers in the map yet (data through 7 Oct 2026). Placed in Medical and scientific domain agents, one of 16 directions in LLM agents and tool use. Builds on 10 of its 47 references that are in the map. First posted on arXiv 16 Feb 2026.

Builds on

10 of 47 references.

References · 10

  1. 2023AutoGen: Enabling Next-Gen LLM Applications via Multi-Agent Conversationcited by 1,906
  2. 2023CAMEL: Communicative Agents for "Mind" Exploration of Large Language Model Societycited by 1,348
  3. 2020BLEURT: Learning Robust Metrics for Text Generationcited by 1,196
  4. 2023RLAIF vs. RLHF: Scaling Reinforcement Learning from Human Feedback with AI Feedbackcited by 615
  5. 2023Eureka: Human-Level Reward Design via Coding Large Language Modelscited by 542
  6. 2020ToTTo: A Controlled Table-To-Text Generation Datasetcited by 267
  7. 2024Trial and Error: Exploration-Based Trajectory Optimization for LLM Agentscited by 194
  8. 2019Handling Divergent Reference Texts when Evaluating Table-to-Text Generationcited by 119
  9. 2018Dynamic Weights in Multi-Objective Deep Reinforcement Learningcited by 96
  10. 2023OpenMM 8: Molecular Dynamics Simulation with Machine Learning Potentialscited by 44

Built on by

Not cited yet.

Similar, not cited

Close in wording, no citation either way

  1. 2026Agentic Discovery of Non-Canonical Antimicrobial Peptides with AMPGAN v3
  2. 2026ProDCARL: Reinforcement Learning-Aligned Diffusion Models for De Novo Antimicrobial Peptide Design
  3. 2026Bridging the Evidence-to-Execution Gap:A Reflective Agent for Multi-Objective Peptide Design
  4. 2026Pepti-Agent: An AI Agent for Peptide Design and Optimization
  5. 2026Purely Agent-Driven Black-Box Optimization for Biological Design
  6. 2025OmegAMP: Targeted AMP Discovery via Biologically Informed Generation
  7. 2025PepThink-R1: LLM for Interpretable Cyclic Peptide Optimization with CoT SFT and Reinforcement Learning
  8. 2025Fine-Tuning and Prompt Engineering of LLMs, for the Creation of Multi-Agent AI for Addressing Sustainable Protein Production Challenges